These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Hormonal contraception--side effects and surgical aspects (author's transl)]. Göretzlehner G; Carol W; Köhler G Zentralbl Chir; 1980; 105(24):1601-16. PubMed ID: 7015744 [TBL] [Abstract][Full Text] [Related]
4. Current perspectives on combination oral contraceptives. Smith MA; Youngkin EQ Clin Pharm; 1984; 3(5):485-96. PubMed ID: 6386284 [TBL] [Abstract][Full Text] [Related]
5. [Emotional changes under oral contraceptives]. Prill HJ; Heister R Med Klin; 1971 Feb; 66(6):192-4. PubMed ID: 5279036 [TBL] [Abstract][Full Text] [Related]
6. The formulation of oral contraceptives: does the amount of estrogen make any clinical difference? Speroff L Johns Hopkins Med J; 1982 May; 150(5):170-6. PubMed ID: 7043035 [TBL] [Abstract][Full Text] [Related]
7. [Rationale for prescribing oral contraceptives]. Teichmann AT Wien Med Wochenschr; 1998; 148(7):171-4. PubMed ID: 9700865 [TBL] [Abstract][Full Text] [Related]
9. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives]. Cianci A; De Leo V Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832 [TBL] [Abstract][Full Text] [Related]
10. Present status of oral contraceptives: 1. effectiveness; basis for selection; side effects; metabolic changes. Kistner RW Drug Ther (NY); 1971 Dec; 1(12):14-29. PubMed ID: 12306285 [TBL] [Abstract][Full Text] [Related]
11. IARC monographs program on carcinogenicity of combined hormonal contraceptives and menopausal therapy. Schneider HP; Mueck AO; Kuhl H Climacteric; 2005 Dec; 8(4):311-6. PubMed ID: 16390765 [TBL] [Abstract][Full Text] [Related]
12. Cardiovascular disease and use of oral and injectable progestogen-only contraceptives and combined injectable contraceptives. Results of an international, multicenter, case-control study. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Contraception; 1998 May; 57(5):315-24. PubMed ID: 9673838 [TBL] [Abstract][Full Text] [Related]
13. [Various possible adverse effects of synthetic estroprogestinic preparations at the extragenital level (review of the literature and personal contributions)]. Lauro V Arch Ostet Ginecol; 1969; 74(3):193-235. PubMed ID: 5402696 [No Abstract] [Full Text] [Related]
14. [A further case of hepatocytic adenoma following oestrogen-progestogen treatment. Review of the published literature (author's transl)]. Grandjean JP; Vignal J; Seffert P; Mestrallet G; Beurlet J; Quiviger P Ann Chir; 1979 May; 33(5):361-70. PubMed ID: 389138 [No Abstract] [Full Text] [Related]
17. Oral contraceptives. Shearman RP Aust Fam Physician; 1984 Sep; 13(9):685-91. PubMed ID: 6508652 [TBL] [Abstract][Full Text] [Related]
18. Relationship of estrogens and oral contraceptives to endometrial cancer in animals and women. Drill VA J Reprod Med; 1980 Jan; 24(1):5-13. PubMed ID: 6987399 [TBL] [Abstract][Full Text] [Related]
19. Contraception. Swyer GI Trans Med Soc Lond; 1972; 88():191-7. PubMed ID: 4353229 [TBL] [Abstract][Full Text] [Related]
20. [Who is still afraid of the pill today? The development of hormonal contraception ('the pill') in the last 20 years. Current status]. van Vliet M Tijdschr Ziekenverpl; 1982 Oct; 35(20):659-63. PubMed ID: 6923669 [No Abstract] [Full Text] [Related] [Next] [New Search]